We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
REJUNON (Juno Pharmaceuticals Pty Ltd)
Product name
REJUNON
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
107 (120 working days)
Active ingredients
testosterone undecanoate
Registration type
New generic medicine
Indication
Testosterone replacement in primary and secondary male hypogonadism.